Business Description
Glycorex Transplantation AB
ISIN : SE0000524530
Share Class Description:
FRA:O33: Class BDescription
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -1.75 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.31 | |||||
| Beneish M-Score | -4.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.4 | |||||
| 3-Year EPS without NRI Growth Rate | -55 | |||||
| 3-Year FCF Growth Rate | -160.1 | |||||
| 3-Year Book Growth Rate | -22.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.22 | |||||
| 9-Day RSI | 60.92 | |||||
| 14-Day RSI | 58.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 423.24 | |||||
| Days Sales Outstanding | 80.24 | |||||
| Days Payable | 105.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.17 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.91 | |||||
| Operating Margin % | -88.92 | |||||
| Net Margin % | -89.7 | |||||
| FCF Margin % | -19.97 | |||||
| ROE % | -55.75 | |||||
| ROA % | -38.37 | |||||
| ROIC % | -46.35 | |||||
| ROC (Joel Greenblatt) % | -137.19 | |||||
| ROCE % | -47.5 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.51 | |||||
| PB Ratio | 2.84 | |||||
| Price-to-Tangible-Book | 7.03 | |||||
| EV-to-EBIT | -5.11 | |||||
| EV-to-EBITDA | -24.15 | |||||
| EV-to-Revenue | 4.49 | |||||
| EV-to-FCF | -17.69 | |||||
| Price-to-Projected-FCF | 14.05 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Earnings Yield (Greenblatt) % | -19.59 | |||||
| FCF Yield % | -4.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Glycorex Transplantation AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.729 | ||
| EPS (TTM) (€) | -0.033 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 58.39 | ||
| 14-Day ATR (€) | 0.012263 | ||
| 20-Day SMA (€) | 0.117935 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.0768 - 0.1795 | ||
| Shares Outstanding (Mil) | 73.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Glycorex Transplantation AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Glycorex Transplantation AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Glycorex Transplantation AB Frequently Asked Questions
What is Glycorex Transplantation AB(FRA:O33)'s stock price today?
The current price of FRA:O33 is €0.14. The 52 week high of FRA:O33 is €0.18 and 52 week low is €0.08.
When is next earnings date of Glycorex Transplantation AB(FRA:O33)?
The next earnings date of Glycorex Transplantation AB(FRA:O33) is 2025-02-28 Est..
Does Glycorex Transplantation AB(FRA:O33) pay dividends? If so, how much?
Glycorex Transplantation AB(FRA:O33) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers